GLP-1 receptor agonists for obesity treatment

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

111 papers

Active filtersClassification:Supporting

Showing 109-111 of total 111 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2014OpenAlexSupporting evidence556 citations

Adverse Effects of GLP-1 Receptor Agonists

Theodosios D. Filippatos; Thalia Panagiotopoulou; Moses Elisaf

Jan 1, 2014The Review of Diabetic Studies

2008OpenAlexSupporting evidence1,127 citations

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes

Michael A. Nauck; Anders Frid; Kjeld Hermansen; Nalini S. Shah; Tsvetalina Tankova; Ismail Mitha; Milan Zdravković; Maria Düring; David R. Matthews; for the LEAD-2 Study Group

Oct 17, 2008Diabetes Care

1995CrossrefSupporting evidence24 citations

Obesity Level and Attrition: Support for Patient‐Treatment Matching in Obesity Treatment

Matthew M. Clark; Barrie J. Guise; Raymond S. Niaura

Jan 1, 1995Obesity Research